Who owns Enthera Pharmaceuticals?

Enthera Pharmaceuticals is currently owned by Sofinnova Partners, through Sofinnova Capital X, since 2022.

When did Sofinnova Partners acquire Enthera Pharmaceuticals?

Sofinnova Partners acquired Enthera Pharmaceuticals in 2022 (active for 4 years).

Home/Companies/Biotech/Enthera Pharmaceuticals

Enthera Pharmaceuticals

Biotech·

Italy·Active·4yr hold

Enthera Pharmaceuticals is a healthcare / biotech company, headquartered in Italy.

Entry

2022

Hold

4yr

Status

Active

Est. EV

–

Investor

Sofinnova Partners

Key facts

HQItaly

SectorHealthcare / Biotech

Italian biotech developing first-in-class biologics to re-establish stem cell capabilities and treat specific autoimmune conditions.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Sofinnova Capital X

Other portfolio companies in the same fund.

DISCO Pharmaceuticals

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings